ACSL4 and nonpapillary renal cell carcinoma: Meanwhile, our experimental results demonstrate that when SPI1 is highly expressed or ACSL4 is lowly expressed, the combination of ferroptosis inducers with EZH2 inhibitors can promote ferroptosis in ccRCC.